News & Event
- Home
- News
- News & Event
Pharma Research Bio held a groundbreaking ceremony for the 2nd plant in Gangneung Science Industrial Complex
Pharma Research Bio, a leading bio company in Gangneung Science and General Industrial Complex, held a groundbreaking ceremony for its second plant in the Science Industrial Complex on December 6.
With a total investment of KRW 21.9 billion, the second plant will be expand on its existing site in 916-5 Daejeon-dong to a total area of 8,166㎡ with three floors above the ground.
The expansion of the factory is aimed at early construction of infrastructure, such as securing production volume in response to an increase in domestic sales and exports, and stable production after obtaining permission for overseas items in the Chinese and European markets.
The city expects the expansion of the second plant would result in creating 30 new jobs.
For this purpose, the city plans to continue providing administrative and financial support to ensure that Pharma Research Bio becomes an anchor company, driving the local bio industry.
Pharma Research Bio, since establishing the first plant in the Science Industrial Complex in October 2009, has rapidly grown into a botolinum toxin specializing company with 70 employees and current sales record reaching KRW 12.5 billion.
Earlier in June, Gangwon State, Gangneung-si, and Pharma Research Bio signed an MOU on investment for the payment of KRW 4.2 billion in total as investment promotion subsidies.
yoo21@yna.co.kr
Source Text
** This article was translated from Korean.
Date
2023.12.14
Views
133
According to Yonhap News,
Pharma Research Bio, a leading bio company in Gangneung Science and General Industrial Complex, held a groundbreaking ceremony for its second plant in the Science Industrial Complex on December 6.
With a total investment of KRW 21.9 billion, the second plant will be expand on its existing site in 916-5 Daejeon-dong to a total area of 8,166㎡ with three floors above the ground.
The expansion of the factory is aimed at early construction of infrastructure, such as securing production volume in response to an increase in domestic sales and exports, and stable production after obtaining permission for overseas items in the Chinese and European markets.
The city expects the expansion of the second plant would result in creating 30 new jobs.
For this purpose, the city plans to continue providing administrative and financial support to ensure that Pharma Research Bio becomes an anchor company, driving the local bio industry.
Pharma Research Bio, since establishing the first plant in the Science Industrial Complex in October 2009, has rapidly grown into a botolinum toxin specializing company with 70 employees and current sales record reaching KRW 12.5 billion.
Earlier in June, Gangwon State, Gangneung-si, and Pharma Research Bio signed an MOU on investment for the payment of KRW 4.2 billion in total as investment promotion subsidies.
yoo21@yna.co.kr
Source Text
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
Source: Yonhap News (December 6, 2023)
** This article was translated from Korean.